DISEASE-ACTIVITY AND JOINT DAMAGE PROGRESSION IN EARLY RHEUMATOID-ARTHRITIS - RELATION TO IGG, IGA, AND IGM RHEUMATOID-FACTOR

被引:66
|
作者
EBERHARDT, KB
TRUEDSSON, L
PETTERSSON, H
SVENSSON, B
STIGSSON, L
EBERHARDT, JL
WOLLHEIM, FA
机构
[1] UNIV LUND HOSP,DEPT MED MICROBIOL,S-22185 LUND,SWEDEN
[2] UNIV LUND HOSP,DEPT DIAGNOST RADIOL,S-22185 LUND,SWEDEN
[3] UNIV LUND HOSP,INST OCCUPAT & ENVIRONM MED,S-22185 LUND,SWEDEN
[4] HELSINGBORG GEN HOSP,RHEUMATOL UNIT,HELSINGBORE,SWEDEN
[5] HELSINGBORG GEN HOSP,DEPT DIAGNOST RADIOL,HELSINGBORG,SWEDEN
关键词
D O I
10.1136/ard.49.11.906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical and biochemical correlations with joint damage progression over two years in a consecutive group of 68 patients with rheumatoid arthritis with disease duration of less than two years are reported. Joint damage was assessed with Larsen's severity scale and a measure of change in progression rate constructed. Initial haemoglobin concentration, Ritchie index, and Waaler-Rose titre in combination accounted for one third of the variance in joint damage progression. Rheumatoid factor (RF) concentrations were followed with enzyme linked immunosorbent assays (ELISAs) for IgG RF, IgA RF, and IgM RF. The RF concentrations, except IgG RF, decreased with time; significant correlations between RFs and disease activity were few and barely clinically useful. After two years IgG RF correlated significantly with a radiological score if early non-erosive changes were omitted. All RFs tended to correlate better with this radiological score at all three observation points. Analyses of the change in progression rate indicated a time delay between development of radiographic changes and increase of IgG RF. These results suggest an indirect relation between RFs and joint damage. Clinical and biochemical improvements in early RA occur despite joint damage progression, and conventional markers have insufficient predictive value.
引用
收藏
页码:906 / 909
页数:4
相关论文
共 50 条
  • [31] INVITRO SYNTHESIS OF IGM AND IGM RHEUMATOID-FACTOR IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID-ARTHRITIS
    ALARCON, GA
    KOOPMAN, WJ
    SCHROHENLOHER, RE
    CLINICAL RESEARCH, 1981, 29 (01): : A162 - A162
  • [33] INVITRO SYNTHESIS OF IGM AND IGM RHEUMATOID-FACTOR IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID-ARTHRITIS
    ALARCON, GA
    KOOPMAN, WJ
    SCHROHENLOHER, RE
    CLINICAL RESEARCH, 1980, 28 (05): : A888 - A888
  • [34] BONE METABOLISM IN RHEUMATOID-ARTHRITIS - RELATION TO DISEASE-ACTIVITY
    EGGELMEIJER, F
    PAPAPOULOS, SE
    WESTEDT, ML
    VANPAASSEN, HC
    DIJKMANS, BAC
    BREEDVELD, FC
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (05): : 387 - 391
  • [35] THE RELATION BETWEEN STRESS AND DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS
    THOMASON, BT
    BRANTLEY, PJ
    JONES, GN
    DYER, HR
    MORRIS, JL
    JOURNAL OF BEHAVIORAL MEDICINE, 1992, 15 (02) : 215 - 220
  • [36] THE MAJOR RHEUMATOID-FACTOR CROSS-REACTIVE IDIOTYPE AND IGA RHEUMATOID-FACTOR IN JUVENILE RHEUMATOID-ARTHRITIS
    RAMAKRISHNAN, TP
    ILOWITE, NT
    WEDGWOOD, JF
    HATAM, L
    VALACER, DJ
    BONAGURA, VR
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (07) : 1068 - 1072
  • [37] IGG RHEUMATOID-FACTOR IN PURIFIED IGG FRACTIONS AND WHOLE SERA IN RHEUMATOID-ARTHRITIS
    HARATS, N
    EILAT, D
    RUBINOW, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (01) : 220 - 220
  • [38] MONOCLONAL IGM RHEUMATOID-FACTOR IN A PATIENT WITH RHEUMATOID-ARTHRITIS AND HYPERVISCOSITY SYNDROME
    RIETVELD, AP
    VANPAASSEN, HC
    NETHERLANDS JOURNAL OF MEDICINE, 1983, 26 (06): : 157 - 159
  • [39] LOW-MOLECULAR WEIGHT IGM RHEUMATOID-FACTOR IN RHEUMATOID-ARTHRITIS
    ROBERTSTHOMSON, PJ
    WERNICK, RM
    ZIFF, M
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (06): : 715 - 715
  • [40] IGM RHEUMATOID-FACTOR (RF), IGARF, IGE RF, AND IGG RF DETECTED BY ELISA IN RHEUMATOID-ARTHRITIS
    GIOUDPAQUET, M
    AUVINET, M
    RAFFIN, T
    GIRARD, P
    BOUVIER, M
    LEJEUNE, E
    MONIER, JC
    ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (01) : 65 - 71